Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gastric cancer].

Taira Kinoshita1, Masaru Konishi, Toshio Nakagohri

  • 1Dept. of Upper Abdominal Surgical Oncology, National Cancer Center Hospital East.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiomics Analysis for Predicting Medication-Related Osteonecrosis of the Jaw Using Computed Tomography.

Oral diseases·2026
Same author

Upregulation of GnT-IVa and Its Critical Roles in ATRA-Induced Differentiation of Acute Promyelocytic Leukemia Cells.

Biomolecules·2026
Same author

Association between an inpatient oral self-care promotion programme and hospital-acquired infections: a propensity score-matched cohort study.

The Journal of hospital infection·2026
Same author

Applying Artificial Intelligence Technologies to Detect Pancreatic Ductal Adenocarcinoma Using Routine Laboratory Tests: A Pilot Study with the Aid of Machine Learning Suitable for a Small Data Analysis.

Internal medicine (Tokyo, Japan)·2026
Same author

Correlation between drilling torque and cone-beam CT gray values: an exploratory clinical study on bone density assessment using a measurement drill.

BMC oral health·2026
Same author

Timing of perioperative oral care and postoperative pneumonia: a propensity score-matched cohort study.

BMC oral health·2026
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Adjuvant chemotherapy with UFT shows promise for advanced gastric cancer after surgery. Further large-scale trials are needed to confirm its efficacy as definitive evidence.

Area of Science:

  • Oncology
  • Clinical Trials
  • Gastroenterology

Context:

  • Advanced gastric cancer treatment relies on adjuvant therapy post-resection.
  • Past adjuvant therapy trials yielded mixed results, necessitating rigorous Evidence-Based Medicine (EBM) approaches.
  • High-quality clinical trials, exemplified by the Japan Oncology Group (JCOG), are crucial for advancing treatment efficacy.

Purpose:

  • To evaluate the efficacy of adjuvant therapy in curatively resected advanced gastric cancer.
  • To address the need for large-scale randomized control trials (RCTs) in gastric cancer adjuvant therapy.
  • To build upon previous trial data and establish definitive evidence for adjuvant chemotherapy.

Summary:

  • The National Surgical Adjuvant Study of Gastric Cancer (N. SAS-GC) demonstrated a statistically significant survival benefit with UFT adjuvant chemotherapy in a well-designed RCT.

Related Experiment Videos

  • While encouraging, the N. SAS-GC trial's sample size limits its conclusiveness.
  • Further large-scale RCTs with adequate sample sizes are required to definitively prove the efficacy of adjuvant chemotherapy for advanced gastric cancer.

    • Impact:

    • The N. SAS-GC trial provides positive momentum after a period of negative adjuvant trial outcomes.
    • Findings suggest UFT as a potential adjuvant chemotherapy agent for gastric cancer.
    • Future trials will aim to provide definitive evidence, potentially guiding standard treatment protocols.